Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125214323 | 12521432 | 3 | F | 20160630 | 20160701 | 20160707 | EXP | IN-JNJFOC-20160627800 | JANSSEN | ALEXANDER ST, KATTULA D, MANNAM P, IYYADURAI R. RISPERIDONE INDUCED BENIGN INTRACRANIAL HYPERTENSION LEADING TO VISUAL LOSS. INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE 2016;38 (3):249-51. | 40.00 | YR | A | F | Y | 0.00000 | 20160707 | MD | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125214323 | 12521432 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | FOR THE PAST 1 YEAR | Y | U | 20272 | 4 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125214323 | 12521432 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125214323 | 12521432 | OT |
| 125214323 | 12521432 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125214323 | 12521432 | Benign intracranial hypertension | |
| 125214323 | 12521432 | Headache | |
| 125214323 | 12521432 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |